Lynch  Syndrome  Ireland

Category: Uncategorized


Unmet need: Cancer Genetics Services

Environmental scan sponsored by Irish Cancer Society by Prof. Josephine Hegarty UCC

Read More

Beginners Guide to Lynch Syndrome

https://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/clinical-units/cancer-genetics-unit

Read More

“Bowel cancer doesn’t discriminate on gender or age…We need to be having a more open public conversation about it and need to highlight hereditary cancer syndromes so we can get better at identifying the families affected and give them the opportunity to reduce their cancer burden. It would save so many lives.”

https://www.irishtimes.com/life-and-style/health-family/hereditary-cancer-syndromes-are-by-no-means-a-death-sentence-1.4517765?fbclid=IwAR2Ef00DgVaiK-7q-mMIVG2mvUqQOXRkv0hCmADdqYT200_t3TQ0V1-jehc#.YGbVYwAGKRg.facebook

Read More

Lynch Syndrome Awareness Day. (22nd March 2021)

Read More

NCCN: Genetic/Familial High Risk Assessment: Colorectal. (1.2020)

https://www.nccn.org/professionals/physician_gls/default.aspx#genetics_colon

Read More

World Cancer Day 4th February 2021

Choirs for Cancer Please tune in to #ChoirsforCancer2021 hosted on YouTube on 4th Feb (#WorldCancerDay) at 7pm (GMT) – see http://bit.ly/3qJOwBF

Read More

Let’s talk and think Lynch & prevent the associated cancers.

Some really important information about Lynch Syndrome that every gynaecologist should know.

Read More

Ongoing research being conducted at the School of Psychology, NUI Galway about experiences as a Lynch Syndrome carrier in Ireland.

Read More

The Final Blog

Originally posted on Bowel Cancer Man:
Since my husband Patrick died in January this year it’s felt very special to continue his blog. Over the last few months, I’ve shared my experience of grief and the impact of Patrick’s illness…

Read More

Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants

Conclusion: Little benefit is gained by performing RRS before 40 years of age and premenopausal BSO in path_MSH6 and path_PMS2 heterozygotes has no measurable benefit for mortality. These findings may aid decision making for women with LS who are considering RRS….

Read More